AxoGen, Inc.
AXGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $60,082 | $56,662 | $48,560 | $49,405 |
| % Growth | 6% | 16.7% | -1.7% | – |
| Cost of Goods Sold | $14,089 | $14,644 | $13,627 | $11,830 |
| Gross Profit | $45,993 | $42,018 | $34,933 | $37,575 |
| % Margin | 76.6% | 74.2% | 71.9% | 76.1% |
| R&D Expenses | $7,565 | $6,853 | $6,091 | $6,731 |
| G&A Expenses | $10,836 | $9,689 | $9,458 | $8,830 |
| SG&A Expenses | $36,516 | $33,493 | $30,503 | $28,854 |
| Sales & Mktg Exp. | $25,680 | $23,804 | $21,045 | $20,024 |
| Other Operating Expenses | $0 | $0 | $0 | -$27 |
| Operating Expenses | $44,081 | $40,346 | $36,594 | $35,558 |
| Operating Income | $1,912 | $1,672 | -$1,661 | $2,017 |
| % Margin | 3.2% | 3% | -3.4% | 4.1% |
| Other Income/Exp. Net | -$1,204 | -$1,093 | -$2,173 | -$1,567 |
| Pre-Tax Income | $708 | $579 | -$3,834 | $450 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $708 | $579 | -$3,834 | $450 |
| % Margin | 1.2% | 1% | -7.9% | 0.9% |
| EPS | 0.02 | 0.013 | -0.085 | 0.01 |
| % Growth | 58.7% | 114.9% | -948% | – |
| EPS Diluted | 0.013 | 0.012 | -0.085 | 0.009 |
| Weighted Avg Shares Out | 45,905 | 45,605 | 45,204 | 44,877 |
| Weighted Avg Shares Out Dil | 45,905 | 45,605 | 45,204 | 48,065 |
| Supplemental Information | – | – | – | – |
| Interest Income | $225 | $225 | $0 | $0 |
| Interest Expense | $10,211 | $1,977 | $2,250 | $1,801 |
| Depreciation & Amortization | $1,730 | $1,820 | $1,882 | $1,915 |
| EBITDA | $12,649 | $4,376 | $298 | $4,165 |
| % Margin | 21.1% | 7.7% | 0.6% | 8.4% |